Arcturus Therapeutics Holdings ARCT Earnings Call Transcripts

NASDAQ ARCT
$9.31 -0.08 (-0.85%)
At close: Nov 11, 2026 · 4:00 PM EST
5 earnings calls on file for Arcturus Therapeutics Holdings, from Q1 2020 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Arcturus Therapeutics Holdings Q3 2026 Earnings Call

Nov 5, 2026 7,021 words · 31 min read
  • Neda SafarzadehVice President, Head of Investor Relations, Public Relations and Marketing
  • Joseph PaynePresident and Chief Executive Officer
  • Dennis MulroyChief Financial Officer
  • Padmanabh ChivukulaChief Scientific Officer and Chief Operating Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Arcturus Therapeutics Holdings Earnings Call Transcripts

Calls5
LatestNov 5, 2026
SinceQ1 2020

Fiscal 2026

Fiscal 2025

Fiscal 2020

All 5 Arcturus Therapeutics Holdings transcripts Register to get access to Arcturus Therapeutics Holdings’s earnings call transcripts.